Thrivent Financial For Lutherans Viking Therapeutics, Inc. Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 28,251 shares of VKTX stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,251
Previous 27,503
2.72%
Holding current value
$1.2 Million
Previous $1.46 Million
22.7%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VKTX
# of Institutions
474Shares Held
65.6MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$432 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$256 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$199 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$90 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$79.7 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.26B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...